Stifel Financial Corp maintained its position in shares of Sensus Healthcare, Inc. (NASDAQ:SRTS) during the second quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 113,630 shares of the company’s stock at the close of the second quarter. Stifel Financial Corp owned about 0.84% of Sensus Healthcare worth $457,000 at the end of the most recent quarter.
Separately, B. Riley Financial Inc. purchased a new position in Sensus Healthcare in the second quarter worth about $421,000. 8.09% of the stock is owned by hedge funds and other institutional investors.
TRADEMARK VIOLATION WARNING: This news story was reported by Community Financial News and is the sole property of of Community Financial News. If you are accessing this news story on another website, it was illegally copied and reposted in violation of US and international trademark & copyright laws. The original version of this news story can be viewed at https://www.com-unik.info/2017/11/01/sensus-healthcare-inc-srts-stake-held-by-stifel-financial-corp.html.
In other Sensus Healthcare news, CEO Joseph C. Sardano sold 13,320 shares of the stock in a transaction dated Wednesday, September 6th. The shares were sold at an average price of $6.00, for a total value of $79,920.00. Following the completion of the sale, the chief executive officer now owns 1,614,099 shares in the company, valued at approximately $9,684,594. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink. Also, CEO Joseph C. Sardano sold 8,167 shares of the stock in a transaction dated Thursday, August 24th. The shares were sold at an average price of $6.00, for a total transaction of $49,002.00. Following the completion of the sale, the chief executive officer now owns 1,637,891 shares of the company’s stock, valued at approximately $9,827,346. The disclosure for this sale can be found here. In the last quarter, insiders sold 98,551 shares of company stock valued at $591,306. 41.70% of the stock is owned by insiders.
Sensus Healthcare, Inc. (SRTS) opened at 5.75 on Wednesday. Sensus Healthcare, Inc. has a 52-week low of $3.38 and a 52-week high of $6.30. The stock’s market cap is $77.56 million. The company has a 50-day moving average price of $5.42 and a 200 day moving average price of $5.44.
Sensus Healthcare (NASDAQ:SRTS) last released its quarterly earnings data on Thursday, August 3rd. The company reported ($0.06) EPS for the quarter, beating the Zacks’ consensus estimate of ($0.14) by $0.08. The company had revenue of $4.97 million during the quarter, compared to the consensus estimate of $4.50 million. Sensus Healthcare had a negative net margin of 13.31% and a negative return on equity of 16.40%. On average, analysts expect that Sensus Healthcare, Inc. will post ($0.33) earnings per share for the current year.
Sensus Healthcare Company Profile
Sensus Healthcare, Inc, formerly Sensus Healthcare, LLC, is a manufacturer of superficial radiation therapy devices. The Company designs, manufactures and markets medical devices specializing in the treatment of non-melanoma skin cancers and other skin conditions, such as keloids, with superficial radiation therapy.
Want to see what other hedge funds are holding SRTS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Sensus Healthcare, Inc. (NASDAQ:SRTS).
What are top analysts saying about Sensus Healthcare Inc.? - Enter your email address in the form below to receive our free daily email newsletter that contains the latest headlines and analysts' recommendations for for Sensus Healthcare Inc. and related companies.